Cargando…
纯化供者CD34(+)细胞输注治疗单倍型造血干细胞移植后移植物功能不良12例临床分析
OBJECTIVE: To evaluate the efficacy and safety of purified CD34(+) stem cell boost in the treatment of poor graft function (PGF) after allogeneic hematopoietic stem cell transplantation (HSCT). METHODS: 12 patients with poor graft function, reported in our hospital during January 2014 to March 2018,...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348294/ https://www.ncbi.nlm.nih.gov/pubmed/30369204 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.10.008 |
Ejemplares similares
-
单倍型造血干细胞移植和HLA相合同胞供者造血干细胞移植治疗急性B淋巴细胞白血病的回顾性比较研究
Publicado: (2022) -
化疗联合供者淋巴细胞输注对异基因造血干细胞移植后微小残留病阳性患者慢性移植物抗宿主病及预后的影响
Publicado: (2019) -
单倍型造血干细胞移植后原发性植入功能不良对巨细胞病毒肺炎的影响
Publicado: (2020) -
同一供者异基因CD19-CAR-T细胞输注序贯造血干细胞移植治疗B细胞急性淋巴细胞白血病二例报告并文献复习
Publicado: (2020) -
完整家系中KIR单体型对父母亲缘供者单倍体造血干细胞移植预后的影响
Publicado: (2016)